You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic esophagogastric adenocarcinomas

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophagogastric Adenocarcinoma Trial (Sacituzumab govitecan)

Not yet recruiting
  • Esophagogastric Adenocarcinoma
  • Sacituzumab govitecan
  • (no location specified)
Nov 9, 2023

Gastric or Esophagogastric Junction Adenocarcinoma Trial (nimotuzumab plus paclitaxel, plus paclitaxel)

Not yet recruiting
  • Gastric or Esophagogastric Junction Adenocarcinoma
  • nimotuzumab plus paclitaxel
  • placebo plus paclitaxel
  • (no location specified)
Aug 3, 2023

Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab)

Completed
Has Results
  • Esophageal Carcinoma
  • Esophagogastric Junction Carcinoma
  • pembrolizumab
  • (no location specified)
Aug 18, 2022

Esophagogastric Cancer, HER2-Negative Trial in United States (regorafenib, nivolumab, FOLFOX chemo with oxaliplatin)

Active, not recruiting
  • Esophagogastric Cancer
  • HER2-Negative
  • Basking Ridge, New Jersey
  • +6 more
Nov 23, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of the Gastroesophageal Junction Trial in France (Regorafenib and Irinotecan,

Terminated
  • Adenocarcinoma of the Stomach
  • Adenocarcinoma of the Gastroesophageal Junction
  • Angers, France
  • +26 more
Jul 26, 2022

Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab, paclitaxel, docetaxel)

Completed
Has Results
  • Esophageal Carcinoma
  • Esophagogastric Junction Carcinoma
  • pembrolizumab
  • +3 more
  • (no location specified)
May 5, 2022

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

Recruiting
  • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
  • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
  • Guangzhou, Guangdong, China
    Cancer center of Sun Yat-sen University
Jul 20, 2022

Gastric Cancer, Cancer of Stomach, Gastric Adenocarcinoma Trial in Woodville South (IMU-131, Irinotecan or Paclitaxel,

Not yet recruiting
  • Gastric Cancer
  • +5 more
  • IMU-131
  • +2 more
  • Woodville South, South Australia, Australia
    The Queen Elizabeth Hospital
Apr 12, 2022

Gastric Cancer Trial in Frankfurt am Main (5-Fluorouracil, Leucovorin, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Feb 21, 2022

Head Neck Cancers - Salivary Gland Trial in Shanghai (Surufatinib)

Recruiting
  • Head and Neck Cancers - Salivary Gland
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 28, 2021

Stomach Tumors, Peritoneal Metastases Trial (HIPEC, Paclitaxel-albumin, Tegafur-gimeracil-oteracil potassium)

Not yet recruiting
  • Stomach Neoplasms
  • Peritoneal Metastases
  • HIPEC
  • +3 more
  • (no location specified)
Oct 26, 2021

Gastric Cancer, Esophageal Cancer, Adenocarcinoma Gastric Trial in Germany (Nivolumab, Ipilimumab)

Completed
  • Gastric Cancer
  • +5 more
  • Amberg, Germany
  • +34 more
May 17, 2022

Gastric Carcinoma Stage IV, Esophagogastric Junction Adenocarcinoma Stage IV Trial in Moscow (Irinotecan, Oxaliplatin, 5-FU)

Recruiting
  • Gastric Carcinoma Stage IV
  • Esophagogastric Junction Adenocarcinoma Stage IV
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 11, 2021

Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial in China (pembrolizumab, paclitaxel, docetaxel)

Completed
Has Results
  • Esophageal Carcinoma
  • Esophagogastric Junction Carcinoma
  • pembrolizumab
  • +3 more
  • Hefei, Anhui, China
  • +22 more
Aug 16, 2022

Adenocarcinoma - GEJ, Adenocarcinoma of the Stomach Trial in Bengbu (HER2 Tumor Vaccine, HER2 Tumor Vaccine+ Standard of Care

Recruiting
  • Adenocarcinoma - GEJ
  • Adenocarcinoma of the Stomach
  • HER2 Tumor Vaccine
  • HER2 Tumor Vaccine+ Standard of Care chemotherapy
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Apr 6, 2022

Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)

Completed
Has Results
  • Breast Neoplasms
  • +3 more
  • Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 12, 2022

Esophageal Cancer, Gastric Cancer Trial in United States (pembrolizumab, trastuzumab, capecitabine)

Active, not recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Basking Ridge, New Jersey
  • +7 more
Sep 17, 2021

Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Metastasis Trial in United States (Oxaliplatin, Leucovorin, 5 fluorouracil)

Active, not recruiting
  • Gastric Adenocarcinoma
  • +3 more
  • Duarte, California
  • +6 more
May 10, 2021

Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastric

Completed
  • Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
  • +5 more
  • S-1 de-escalation
  • Chemotherapy by Investigator's choice
  • Heidelberg, Baden-Württemberg, Germany
    NCT-Med. Onkologie
Mar 25, 2021

MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)

Not yet recruiting
  • MSI-H/dMMR Gastroesophageal-junction Cancer
  • MSI-H/dMMR Gastric Cancer
  • (no location specified)
Oct 30, 2023

Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Duarte, South

Withdrawn
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Duarte, California
  • +2 more
Feb 21, 2022

Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)

Recruiting
  • Metastatic Pancreatic Cancer
  • MesoPher
  • Mitazalimab
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Dec 6, 2022

Bladder Cancer, Urethral Cancer, Urachal Cancer Trial in Houston (5-Fluorouracil (5-FU), Leucovorin, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • 5-Fluorouracil (5-FU)
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 18, 2021

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Cholesterol metabolism disruption
  • Quebec city, Quebec, Canada
    CHU de Québec-Université Laval
Oct 17, 2022

Adenocarcinoma of the Stomach, GastroEsophageal Cancer Trial in Germany (Nivolumab, Ipilimumab, mFOLFOX)

Active, not recruiting
  • Adenocarcinoma of the Stomach
  • GastroEsophageal Cancer
  • Amberg, Germany
  • +26 more
Jan 12, 2023